Skip to main content

Advertisement

Table 3 Length of hospital stay, percent creatinine rise, modified Rankin score at discharge and blood product utilization between the study groups

From: Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis

  Non-HES group (n=72) HES group (n=57) *p value
Length of ICU stay 10 (8–13) 14 (11–19.5) 0.001
Length of hospital stay 14 (12–17) 19 (14–26) 0.001
30 day mortality 11 (15.3%) 7 (12.2%) 0.79
Percentage ∆Cr in patients with primary outcome 7.1 (0–27) 12.5 (0–37.5) 0.74
Modified Rankin score (discharge)
0 8 (11.1%) 2 (3.5%) 0.38
1 26 (36.1%) 30 (52.6%)
2 14 (19.4%) 7 (12.3%)
3 7 (9.7%) 4 (7%)
4 5 (6.9%) 6 (10.5%)
5 1 (1.4%) 1 (1.7%)
death 11 (15.3%) 7 (12.3%)
Blood product usage
5% PPF 24.31 (119.85) 26.32 (102.25) 0.51
PRBC 184.65 (428.64) 388.12 (610.98) 0.006
FFP 30.67 (131.42) 82.84 (299.60) 0.43
Platelet 34.04 (105.06) 109.30 (445.32) 0.57
  1. *Mann–Whitney U test was used to compare continuous variables and chi-square test for categorical variables. Data reported as †Median (Interquartile range) ‡Mean (Standard deviation) for continuous variables and count (%) for categorical variables.
  2. ICU Intensive care unit.
  3. ∆Cr Creatinine rise.
  4. PPF Plasma protein fraction (Human).
  5. PRBC Packed red blood cells.
  6. FFP Fresh frozen plasma.